ValueAct成立于2000年，代表机构和富有的个人投资者管理着约15亿美元。ValueAct目前的投资组合包括Advanced Medical Optics Inc.（隐形眼镜;近15％）的股权。该公司成功地挫败了Advanced Medical Optics公司2008年收购博士伦的提议，称Advanced Advanced无法成功吸收其竞争对手。

Founded in 2000, ValueAct manages some $1.5 billion on behalf of institutional and wealthy individual investors. ValueAct's current portfolio includes stakes in Advanced Medical Optics Inc. (contact lenses; nearly 15%). The company successfully thwarted Advanced Medical Optics' proposed acquisition of Bausch & Lomb in 2008, saying Advanced Medical could not successfully absorb its rival.